John V. Duncia

Identification of angiotensin II receptor subtypes

Andrew T. Chiu, William F. Herblin, Dale E. McCall et al. · Biochemical and Biophysical Research Communications · 1989 · 822 citations

Life Sciences, Biochemistry, Pharmacology +12

Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives

David J. Carini, John V. Duncia, Paul E. Aldrich et al. · Journal of Medicinal Chemistry · 1991 · 431 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products

John V. Duncia, Joseph B. Santella, C. Anne Higley et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 406 citations · Full text

Life Sciences, Biochemistry, Pharmacology +11

Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.

Pancras C. Wong, William A. Price, Andrew T. Chiu et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 330 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.

Andrew T. Chiu, Dale E. McCall, William A. Price et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 317 citations

Medicine, Medicinal Chemistry, Pharmacology +13